Statements (44)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:depression
|
gptkbp:administered_by |
injection
oral tablet |
gptkbp:approves |
gptkb:1961
gptkb:FDA |
gptkbp:atccode |
A03 BB01
|
gptkbp:available_on |
generic drug
|
gptkbp:brand |
gptkb:Cuvposa
gptkb:Glycopyrrolate_Injection gptkb:Robinul |
gptkbp:casnumber |
557-73-1
|
gptkbp:chemical_formula |
C19 H28 Br N
|
gptkbp:clinical_trial |
studied for COPD
studied for asthma studied for drooling in children studied for excessive sweating studied for postoperative nausea |
gptkbp:contraindication |
gptkb:Ophthalmology
gptkb:myasthenia_gravis urinary obstruction severe ulcerative colitis |
gptkbp:drug_interactions |
antihistamines
muscle relaxants tricyclic antidepressants other anticholinergics |
gptkbp:formulation |
gptkb:patches
oral solution sublingual tablet |
https://www.w3.org/2000/01/rdf-schema#label |
glycopyrrolate
|
gptkbp:mechanism_of_action |
gptkb:antagonist
|
gptkbp:pharmacokinetics |
half-life 1.5 to 2 hours
oral bioavailability 5% to 10% |
gptkbp:side_effect |
dizziness
constipation dry mouth blurred vision urinary retention |
gptkbp:storage |
store at room temperature
|
gptkbp:used_for |
chronic obstructive pulmonary disease
treating peptic ulcers preoperative medication reducing drooling |
gptkbp:bfsParent |
gptkb:Trixeo_Aerosphere
|
gptkbp:bfsLayer |
5
|